Trial intelligence / Profile preview

Peripheral Edema Resolution in Patients Switched from Amlodipine to Levamlodipine (PERLA)

2024-511312-24-00Phase 2Completed

Sponsor
Zentiva
Start
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of Levamlodipine in hypertension (HTN) and peripheral edema, sponsored by Zentiva. Started Jun 2024; status: completed.

02

Drugs

Levamlodipine
03

Conditions

hypertension (HTN)peripheral edema

Beyond the preview

Go deeper on 2024-511312-24-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-511312-24-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call